Months
Productivity
Acceptance Rate
The Pipeline Doesn't Stall on Science. It Stalls on Leadership
The gap between clinical success and commercial failure is almost always a leadership decision. We validate that before you make yours.
$230 billion in biopharma revenue hits patent expiration by 2030. Consolidation is accelerating. The executives who can lead through acquisition, scale manufacturing, and satisfy regulators simultaneously are the scarcest profile in the market — and they are not applying for your role.
The Right Leaders Are Still Impossible to Find.
Biopharma layoffs rose 16% year-over-year.. Job postings fell 20%. Yet 77% of life sciences employers globally still can’t find the skilled executives they need. The surplus is in the middle. The shortage is at the top—and M&A activity is widening that gap every quarter.
What We Solve in Life Sciences
SMO & Clinical Vacuum
The pool of MD/PhDs with FDA pathway depth and leadership scale is measured in dozens. Large pharma locks them up. Emerging biotechs can’t reach them.
Advanced Therapy CMC Bottleneck
80% of cell therapy failures are manufacturing-related, not clinical. Small-molecule experience doesn’t transfer to viral vectors of radio-pharmaceuticals.
THE AI / Biology War
Pure tech leaders fail in biotech. Biologists can’t build ML pipelines. San Diego, Bay Area, and global pharma compete in a three-way war for a handful of candidates.
Regulatory affairs generation gap
Veterans who navigated small molecules are now expected to master gene therapy, CAR-T, and bispecifics. The mentorship vacuum at VP level is real and widening.
Manufacturing Scale-up Gap
Leaders who’ve navigatged tech transfer, FDA inspections, and large-scale advanced therapy manufacturing are extremely scarce – compounded by CaliBaja’s bicultural complexity.
Succession Pipeline Collapse
60%+ of Gen Z avoid management tracks. Only 20% of HR leaders have successors ready for critical roles. The traditional path to C-suite is being bypassed by the generation expected to fill it.
Download the Life Sciences Hiring Guide
Examples of Roles We Place
2,100+ Life Sciences. (400+ are manufacturers). Our Network.
32 Years Based in this region. The CaliBaja Advantage.
The San Diego–Tijuana (CaliBaja) corridor is home to one of the largest concentrations of life sciences and medical device manufacturing outside the United States. We have operated on both sides of that border for over three decades—building the talent networks that national search firms cannot access from a desk in another city.
Bilingual leadership capability. USMCA and cross-border regulatory fluency. FDA inspection readiness across dual-site US-Mexico operations. These are not competencies we brief for—they’re environments we work in daily.